Safety issues with herbal medicine

Pharmacotherapy

Volumn 20, Issue 3, 2000, Pages 257-269

  Boullata, Joseph I ^a   Nace, Angela M ^b  

^a TEMPLE UNIVERSITY SCHOOL OF PHARMACY   (United States)

^b TEMPLE UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANABOLIC AGENT; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; CENTRAL DEPRESSANT AGENT; CORTICOSTEROID; DIGOXIN; ESTROGEN; HERBACEOUS AGENT; KAVA; KETOCONAZOLE; METHOTREXATE; MONOAMINE OXIDASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; TETRACYCLIC ANTIDEPRESSANT AGENT; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALERIAN; WARFARIN;

DEMOGRAPHY; DRUG CONTRAINDICATION; DRUG INDICATION; DRUG INDUCED DISEASE; DRUG SAFETY; ECHINACEA; EPHEDRA; GARLIC; GINKGO BILOBA; GINSENG; HERBAL MEDICINE; HUMAN; HYPERICUM PERFORATUM; PHARMACIST; REGULATORY MECHANISM; REVIEW; SABAL; TANACETUM PARTHENIUM;

EID: 0034051785     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.20.4.257.34886     Document Type: Review

References (128)

1. Israel D, Youngkin EQ. Herbal therapies for perimenopausal and menopausal complaints. Pharmacotherapy 1997;17: 970-84.
2. Mashour NH, Lin GI, Frishman WH. Herbal medicine for the treatment of cardiovascular disease: clinical considerations. Arch Intern Med 1998;158:2225-34.
3. Wong AHC, Smith M, Boon HS. Herbal remedies in psychiatric practice. Arch Gen Psychiatry 1998;55:1033-44.
4. Miller LG. Herhal medicinals: selected clinical considerations focusing on known or potential drug-herb interactions. Arch Intern Med 1998;158:2200-11.
5. Fontanarosa PB, Lundberg GD. Alternative medicine meets science, JAMA 1998;28:1618-19.
6. Liu C, Douglas RM. Chinese herbal medicines in the treatment of acute respiratory infections: a review of randomized and controlled clinical trials. Med J Aust 1998;169:579-82.
7. Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA 1998;280:1569-75.
8. Anonymous. Dietary supplement industry growth causing fundamental cultural change. FDC Rep 1998;October 12:4.
9. Kassler WJ, Blanc P, Greenblatt R. The use of medicinal herbs by human immunodeficiency virus-infected patients. Arch Intern Med 1991;151:2281-8.
10. Fairfield KM, Eisenberg DM, Davis RB, Libman H, Phillips RS. Patterns of use, expenditures, and perceived efficacy of complementary and alternative therapies in HIV-infected patients. Arch Intern Med 1998;158:2257-64.
11. Kristoffersen SS, Atkin PA, Shenfield GM. Uptake of alternative medicine [letter]. Lancet 1996;347:972.
12. Sugarman J, Burk L. Physicians' ethical obligations regarding alternative medicine. JAMA 1998;280:1623-5.
13. Anonymous. Pharmacists' role in selling dietary supplements questioned. FDC Rep 1998;March 9:3-5.
14. McCormick E. For one Tennessee pharmacist, herbal medicines are making a difference between profit and failure. Pharmacy Times 1997;May:73-7.
15. Abdel-Rahman SM, Nahata MC. Perspectives on alternative medicine. Ann Pharmacother 1997;31:1397-1400.
16. Davis NM. Natural products and food supplements: where are our professional organizations? [editorial] Hosp Pharm 1997;32:1596.
17. Thompson CA. Adverse reactions to alternative medicine [editorial]. Am J Health-Syst Pharm 1997;54:1707.
18. Krinsky DL, Natural products: show me the data [editorial]. Am J Health-Syst Pharm 1998;55:125.
19. Barclay TS, Tsouranis C, McCart GM. Glucosamine: selecting appropriate study exclusion criteria. Ann Pharmacother 1998;32:1371-2.
20. Angell M, Kassirer JP. Alternative medicine - the risks of untested and unregulated remedies. N Engl J Med 1998;339:839-41.
21. Marsa L. If it's on the shelf, it's safe...right? Good Housekeeping 1998;April:112-16, 178.
22. Bunten W. A call for self-regulation [editorial]. J Am Pharm Assoc 1999;39:14.
23. Borchers AT, Hackman RM, Keen CL, Stern JS, Gershwin ME. Complementary medicine: a review of immunomodulatory effects of Chinese herbal medicines. Am J Clin Nutr 1997;66:1303-12.
24. Chan TYK. Monitoring the safety of Chinese herbal medicines in Hong Kong. Ann Pharmacother 1996;30: 1039-40.
25. Murray LW. USP to reevaluate its position on botanicals. Am J Health-Syst Pharm 1998;55:2330, 2332, 2337, 2341.
26. Blumenthal M, Busse WR, Goldberg A, et al, eds. The complete German commission E monographs: therapeutic guide to herbal medicines Austin, TX: American Botanical Council, 1998.
27. Eliason BC. Alternative medicine - the case of herbal remedies. N Engl J Med 1999;340:564.
28. Anonymous. WHO medicinal plant monographs first volume publication. FDC Rep 1998:July 27:5-6.
29. DeSmet PAGM, Brouwers JRBJ. Pharmacokinetic evaluation of herbal remedies: basic introduction, applicability, current status and regulatory needs. Clin Pharmacokinet 1997;32:427-36.
30. United States Pharmacopeial Convention. United States pharmacopeia, 24th ed. Rockville, MD: Author, 1999.
31. Drew AK, Myers SP. Safety issues in herbal medicine: implications for the health professions. Med J Aust 1997;166:538-41.
32. Anonymous. Dietary supplement AERs. FDC Rep 1998;September 7:25.
33. FDA Center for Food Safety and Applied Nutrition database (updated 20 October 1998). Available at: http://vm.cfsan.fda. gov/~dms/aems.html.
34. Tam LS, Chan TYK, Leung WK, Critchley JAJH. Warfarin interactions with Chinese traditional medicines: danshen and methylsalicylate medicated oil. Aust NZJ Med 1995;25:258.
35. Oka K, Ikeshima K, Takahashi N, et al. Different effects of traditional Chinese medicines containing similar herbal constituents on prednisolone pharmacokinetics. J Pharm Pharmacol 1995;47:687-92.
36. Taylor JR, Wilt VM. Probable antagonism of warfarin by green tea. Ann Pharmacother 1999;33:426-8.
37. McRae S. Elevated serum digoxin levels in a patient taking digoxin and Siberian ginseng. Can Med Assoc J 1996;155:293-5.
38. Ernst E. Harmless herbs? A review of the recent literature. Am J Med 1998;104:170-8.
39. Janetzky K, Morreale AP. Probable interaction between warfarin and ginseng. Am J Health-Syst Pharm 1997;54:692-3.
40. Almeida JC, Grimsley EW. Coma from the health store: interaction between kava and alprazolam. Ann Intern Med 1996;125:940-1.
41. Wasser WG, Feldman NS, D'Agati VD. Chronic renal failure after ingestion of over-the-counter chromium picolinate [letter]. Ann Intern Med 1997;126:410.
42. Martin WR, Fuller RE. Suspected chromium picolinate-induced rhabdomyolysis. Pharmacotherapy 1998;18:860-2.
43. Cerulli J, Grabe DW, Gauthier I, Malone M, McGoldrick MD. Chromium picolinate toxicity. Ann Pharmacother 1998;32:428-31.
44. DeSmet PAGM. Health risks of herbal remedies. Drug Saf 1995;13:81-93.
45. DeSmet PAGM, Smeets OSNM. Potential risks of health food products containing yohimbe extracts [letter]. BMJ 1994;309:958.
46. But PPH, Tomlinson B, Cheung KO, et al. Adulterants of herbal products can cause poisoning [letter]. BMJ 1996;313:117.
47. Roy AK, Sinha KK, Chourasia HK. Aflaloxin contamination of some drug plants. Appl Environ Microbiol 1988;54:842-3.
48. Keen RW, Deacon AC, Delves HT, Moreton JA, Frost PG. Indian herbal remedies for diabetes as a cause of lead poisoning. Postgrad Med J 1994;70:113-14.
49. Dunbabin DW, Tallis GA, Popplewell PY, Lee RA. Lead poisoning from Indian herbal medicine (ayurveda). Med J Aust 1992;157:835-6.
50. Wu MS, Hong JJ, Lin JL, et al. Multiple tubular dysfunction induced by mixed Chinese herbal medicines containing cadmium. Nephrol Dial Transplant 1996;11:867-70.
51. Kew J, Morris C, Aihie A, et al. Arsenic and mercury intoxication due to Indian ethnic remedies. BMJ 1993;306:506-7.
52. Pye KG, Kelsey SM, House IM, Newland AC. Severe dyserythropoiesis and autoimmune thrombocytopenia associated with ingestion of kelp supplements [letter]. Lancet 1992;339:1540.
53. Markowitz SB, Nunez CM, Klitzman S, et al. Lead poisoning due to hai ge fen: the porphyrin content of individual erythrocytes. JAMA 1994;271:932-4.
54. Centers for Disease Control. Nonfatal arsenic poisoning in three Hmong patients - Minnesota. MMWR 1984;33:347-9.
55. Centers for Disease Control. Folk remedy-associated lead poisoning in Hmong children - Minnesota. MMWR 1988;32:555-6.
56. Slifman NR, Obermeyer WR, Musser SM, et al. Contamination of botanical dietary supplements by Digitalis lanata. N Engl J Med 1998;339:806-11.
57. Capobianco DJ, Brazis PW, Fox TP. Proximal-muscle weakness induced by herbs [letter]. N Engl J Med 1993;329:1430.
58. Hsu CK, Leo P, Shastry D, et al. Anticholinergic poisoning associated with berbal tea. Arch Intern Med 1995;155: 2245-8
59. Gertner E, Marshall PS, Filandrinos D, Potek AS, Smith TM. Complications resulting from use of Chinese herbal medications containing undeclared prescription drugs. Arthritis Rheum 1995;38:614-17.
60. Diamond JR, Pallone TL. Acute interstitial nephritis following use of Tung Shueh pills. Am J Kidney Dis 1994;24:219-21.
61. Abt AB, Oh JY, Huntington RA, Burkhart KK. Chinese herbal medicine induced acute renal failure. Arch Intern Med 1995;155:211-12.
62. Hughes JR, Higgins EM, Pembroke AC. Oral dexamethasone masquerading as a Chinese herbal remedy [letter]. Br J Dermatol 1994;130:261.
63. Graham-Brown RAC, Bourke JF, Humphrey G. Chinese herbal remedies may contain steroids [letter]. BMJ 1994;308:473.
64. Vander Stricht BI, Parvais OE, Vanhaelen-Fastré RJ, Vanhaelen MH. Remedies may contain cocktail of active drugs [letter]. BMJ 1994;308:1162.
65. Centers for Disease Control and Prevention. Deaths associated with a purported aphrodisiac - New York City. MMWR 1995;44:853-5.
66. DuPont RL, Bogema SC. Benzodiazepines in a health-catalog product [letter]. JAMA 1990;264:695.
67. Chen YF, Chern HM, Chou MH, Ling MF. Identification of adulteration in Chinese herbal preparations with chemical drugs and their toxicities. Ann Emerg Med 1995;26:717.
68. Huang WF, Wen KC, Hsiao ML. Adulteration by synthetic therapeutic substances of iraditional Chinese medicines in Taiwan. J Clin Pharmacol 1997;37:344-50.
69. Keane FM, Munn SE, du Vivier WP, Taylor NF, Higgins EM. Analysis of Chinese herbal creams prescribed for dermatological conditions. BMJ 1999;318:563-4.
70. Larrey D, Vial T, Pauwels A, et al. Hepatitis after germander (Teucrium chamedrys) administration: another instance of herbal medicine hepatotoxicity. Ann Intern Med 1992;117:129-32.
71. Katz M, Saibil F. Herbal hepatitis: subacute hepatic necrosis secondary to chaparral leaf. J Clin Gastroenterol 1990;12:203-6.
72. Centers for Disease Control and Prevention. Chaparral-induced toxic hepatitis - California and Texas, 1992. MMWR 1992;41:812-14.
73. Smith BC, Desmond PV. Acute hepatitis induced by ingestion of the herbal medication chaparral. Aust NZ J Med 1993;23:526.
74. DeSmet PAGM, Van Den Eertwegh AJM, Stricker BHCH. Hepatotoxicity associated with herbal tablets. BMJ 1996;313:92.
75. Melchart D, Linde K, Hager S, Shaw D, Bauer R. Liver enzyme elevations in patients treated with traditional Chinese medicine. JAMA 1999;282:28-9.
76. Centers for Disease Control. Diarrhea from herbal tea - New York, Pennsylvania. MMWR 1978;27:248-9.
77. Ridker PM. Toxic effects of herbal teas. Arch Environ Health 1987;42:133-6.
78. Centers for Disease Control and Prevention. Anticholinergic poisoning associated with an herbal tea - New York City, 1994. MMWR 1995;44:193-5.
79. Winslow LC, Kroll DJ. Herbs as medicines. Arch Intern Med 1998;158:2192-9.
80. Chan TYK, Chan JCN, Tomlinson B, Critchley JAJH. Chinese herbal medicines revisited: a Hong Kong perspective. Lancet 1993;342:1532-4.
81. Kane JA, Kane SP, Jain S. Hepatitis induced by iraditional Chinese herbs; possible toxic components. Gut 1995;36: 146-7.
82. Woolf GM, Petrovic LM, Rojter SE, et al. Acute hepatitis associated with the Chinese herbal product jin bu huan. Ann Intern Med 1994;121:729-35.
83. Bensoussan A, Talley NJ, Hing M, et al. Treatment of irritable bowel syndrome with Chinese herbal medicine. JAMA 1998;280:1585-9.
84. Horowitz RS, Feldhaus K, Dart RC, Stermitz FR, Beck JJ. The clinical spectrum of jin bu huan toxicity. Arch Intern Med 1996;156:899-903.
85. Anderson IB, Mullen WH, Meeker JE, et al. Pennyroyal toxicity: measurement of toxic metabolite levels in two cases and review of the literature. Ann Intern Med 1996;124: 726-34.
86. Laliberté L, Villeneuve JP. Hepatitis after the use of germander, a herbal remedy. Can Med Assoc J 1996;154:1689-92.
87. Lai RS, Chiang AA, Wu MT, et al. Outbreak of bronchiolitis obliterans associated with consumption of Sauropus androgynus in Taiwan. Lancet 1996;348:83-5.
88. Vanherweghem JL, Depierreux M, Tielemans C, et al. Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs. Lancet 1993;341:387-91.
89. Jadoul M, de Plaen JF, Cosyns JP, de Strihou CVY. Adverse-effects from traditional Chinese medicine. Lancet 1993;341:892-3.
90. Siegers CR, von Hertzberg-Lottin E, Schneider B. Anthranoid laxative abuse - a risk for colorectal cancer? Gut 1993;34:1099-1101.
91. Jones TK, Lawson BM. Profound neonatal congestive heart failure caused by maternal consumption of blue cohosh herbal medication. J Pediatr 1998;132:550-2.
92. Grimm W, Müller HH. A randomized controlled trial of the effect of fluid extract of Echinacea purpurea on the incidence and severity of colds and respiratory infections. Am J Med 1999;106:138-43.
93. 1H-NMR spectroscopy. J Nat Prod 1991;54:1516-21.
94. Hepinstall S. Parthenolide content and bioactivity of feverfew: estimation of commercial and authenticated feverfew products. Pharm Pharmacol 1992;44:391-5.
95. Lawson LD. Effect of garlic on serum lipids [letter]. JAMA 1998;280:1568.
96. Bordia A. Effect of garlic on human platelet aggregation in vitro. Atherosclerosis 1978;30:355-60.
97. Rose KD, Croissant PD, Parliament CF, Levin MB. Spontaneous spinal epidural hematoma with associated platelet dysfunction from excessive garlic ingestion: a case report. Neurosurgery 1990;26:880-2.
98. Rosenblatt M, Mindel J. Spontaneous hyphema associated with ingestion of Ginkgo biloba extract [letter]. N Engl J Med 1997;336:1108.
99. Rowin J, Lewis SL. Spontaneous bilateral subdural hematomas associated with chronic Ginkgo biloba ingestion. Neurology 1996;46:1775-6.
100. Vale S. Subarachnoid haemorrhage associated with Ginkgo biloba [letter]. Lancet 1998;352:36.
101. Chong SKF, Oberholzer VG. Ginseng: is there a use in clinical medicine? Postgrad Med J 1988;64:841-6.
102. Dega H, Laporte JL, Frances C, Herson S, Chosidow O. Ginseng as a cause for Stevens-Johnson syndrome? [letter] Lancet 1996;347:1344.
103. Ryu SJ, Chien YY. Ginseng-associated cerebral arteritis. Neurology 1995;45:829-30.
104. Siegel RK. Ginseng abuse syndrome: problems with the panacea. JAMA 1979;241:1614-15
105. Saxe TG. Toxicity of medicinal herbal preparations. Am Fam Physician 1987;35:135-42.
106. González-Seijo JC, Ramos YM, Lastra I. Manic episode and ginseng: report of a possible case. J Clin Psychopharmacol 1995;15:447-8.
107. Greenspan EM. Ginseng and vaginal bleeding [letter]. JAMA 1983;249:2018.
108. Hopkins MP, Androff L, Benninghoff AS. Ginseng face cream and unexplained vaginal bleeding. Am J Obstet Gynecol 1988;159:1121-2.
109. Palmer BV, Montgomery ACV, Monteiro JCMP. Ginseng and mastalgia [letter]. Br Med J 1978;1:1284.
110. Jones BD, Runikis AM. Interaction of ginseng with phenelzine. J Clin Psychopharmacol 1987;7:201-2.
111. Becker BN, Greene J, Evanson J, Chidsey G, Stone WJ. Ginseng-induced diuretic resistance. JAMA 1998,276:606-7.
112. Liberti LE, Dermarderosian A. Evaluation of commercial ginseng products. J Pharm Sci 1978;10:1487-9.
113. Cui J, Garle M, Eneroth P, et al. What do commercial ginseng preparations contain? Lancet 1994;344:134.
114. Siegel RK. Kola, ginseng, and mislabeled herbs [letter]. JAMA 1977;237:25.
115. Anonymous. GNC ginseng recall. FDC Rep 1997;July 21:30.
116. Anonymous. Liquid ginseng recall in Massachusetts. FDC Rep 1997;August 18:26.
117. Klepser TB, Klepser ME. Unsafe and potentially safe herbal therapies. Am J Health-Syst Pharm 1999;56:125-38.
118. Anonymous. Adverse events with ephedra and other botanical dietary supplements. FDA Med Bull 1994;24(2):3.
119. DiPaola RS, Zhang H, Lambert GH, et al. Clinical and biologic activity of an estrogenic herbal combination (PC-SPES) in prostate cancer. N Engl J Med 1998;339:785-91.
120. Wilt TJ, Ishani A, Stark G, et al. Saw palmetto extracts for treatment of benign prostatic hyperplasia: a systematic review. JAMA 1998;280:1604-9.
121. Bennett DA, Phun L, Polk JF, et al. Neuropharmacology of St. John's wort (Hypericum). Ann Pharmacother 1998;32:1201-8.
122. Rey JM, Walter G. Hypericum perforatum (St John's wort) in depression: pest or blessing? Med J Aust 1998;169:583-6.
123. Linde K, Ramirez G, Mulrow CD, et al. St. John's wort for depression: an overview and meta-analysis of randomised clinical trials. BMJ 1996;313:253-8.
124. Bove GM. Acute neuropathy after exposure to sun in a patient treated with St John's wort. Lancet 1998;352:1121-2.
125. Schneck C. St. John's wort and hypomania. J Clin Psychiatry 1998;59:689.
126. Anonymous. Dietary supplements marketing may be regressing to "snake oil." FDC Rep 1998;March 9:5-6.
127. Willey LB, Mady SD, Cobaugh DJ, Wax PM. Valerian overdose: a case report. Vet Hum Toxicol 1995;37:364-5.
128. Garges HP, Varia I, Doraiswamy PM. Cardiac complications and delirium associated with valerian root withdrawal. JAMA 1998;280:1566-7.